Chinese English Japanese Korean

Merck KGaA

Firmenname:Merck KGaA
Telefon:-(+86) 21 2033 8288
E-Mail:sigmaname@qq.com
Nationalität:CHINA
URL: http://www.sigmaaldrich.cn
Produkte insgesamt:292394
756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860

Produktkatalog

Monoclonal Anti-Asic1 antibody produced in mouse
Calcium succinate159389-75-0
L-Azetidine-2-carboxylic acid(S)-Azetidin-2-carbonsure2133-34-8C4H7NO2
2'-METHOXY-5'-METHYLACETOPHENONE20628-07-3C10H12O2
(2,2,2-TRICHLORO-1-(3-O-TOLYL-THIOUREIDO)-ETHYL)-CARBAMIC ACID ETHYL ESTER297141-07-2
3-phenoxy-2-phenylpiperidine hydrochloride1781419-71-3C17H19NO.ClH
4-HO-N'-(1-ME-PROPYLIDENE)-2-OXO-1-PENTYL-1,2-DIHYDRO-3-QUINOLINECARBOHYDRAZIDE1227183-40-5
RCL T254932
2-AMINO-1-(4-BROMOPHENYL)-5-OXO-4-(2-THIENYL)-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBONITRILE311316-24-2C20H16BrN3OS
2-((4-((ANILINOCARBOTHIOYL)AMINO)PHENYL)THIO)-N-(3,4-DIMETHYLPHENYL)ACETAMIDE763128-88-7C23H23N3OS2
Steritest® Symbio Essential Requalification Protocol
Anti-SOX15 (ab2) antibody produced in rabbit
5-(Benzoyl)-2-(4-cyanophenyl)benzimidazole1192541-69-7C21H13N3O
7-HYDROXY-3-PHENOXY-2-TRIFLUOROMETHYL-CHROMEN-4-ONE137460-59-4C16H9F3O4
3-(5-(2-CHLOROPHENYL)-2-FURYL)-N-(2-METHOXYPHENYL)-2-PROPENAMIDE853348-24-0C20H16ClNO3
EIF2AK3 Activator, CCT020312324759-76-4C31H30Br2N4O2
2-(2-Aminoethyl)-4-methylphenol hydrochlorideC9H14ClNO
3,5-bis(4-methoxyphenyl)-4,5-dihydroisoxazole20821-99-2C17H17NO3
3-Benzyl-2,4-pentanedione1134-87-8C12H14O2
(ETO-CARBONYL-4,4-DI-ME-5,5-DIPHENYL-PYRAZOL-YL)-TRIPHENYL-PHOSPHONIUM, CHLORIDE1098216-26-2
2-METHOXY-4-(2-(PHENYLSULFONYL)CARBOHYDRAZONOYL)PHENYL 2,4-DICHLOROBENZOATE880069-01-2C21H16Cl2N2O5S
Leucoagglutinin from P. vulgaris, recombinant
MMPIP479077-02-6C19H15N3O3
1,1'-(4-METHYL-1,3-PHENYLENE)BIS(3-BUTYLUREA)60903-52-8C17H28N4O2
Anti-MRPL38 antibody produced in rabbit
3-{(5E)-5-[(2E)-2-METHYL-3-PHENYL-2-PROPENYLIDENE]-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL}PROPANOIC ACID306323-56-8C16H15NO3S2
11-[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]-7,8,9,10-TETRAHYDROBENZIMIDAZO[1,2-B]ISOQUINOLINE-6-CARBONITRILE459191-84-5C22H25N5O
4-(4-CHLOROBENZYL)-N-(2-ETHOXYBENZYLIDENE)-1-PIPERAZINAMINE306989-19-5C20H24ClN3O
4-FLUORO-N-(4-OXO-2-THIOXO-THIAZOLIDIN-3-YL)-BENZAMIDE379256-28-7
ETHYL 3-(4-BROMOBENZOYL)-8-CYANO-1-INDOLIZINECARBOXYLATE892158-78-0C19H13BrN2O3
Lithium-6Li oxide
Mobius® 2000 L Power MIX carrier w/ hoist, temp sensor, load cells, ASME
Corning® Lambda® plus 12-channel pipettor
16:0 PC-d75181041-62-3C40H80NO8P
METHYL 2,4-DIMETHYL-5-{[(4-OXO-3-PHENYL-3,4,5,6,7,8-HEXAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]ACETYL}-1H-PYRROLE-3-CARBOXYLATE496026-02-9C26H25N3O4S2
Arjunetin31297-79-7C36H58O10
Anti-CLEC4C antibody produced in rabbit
Monoclonal Anti-NEK4, (C-terminal) antibody produced in mouse
Monoclonal Anti-TAF5L antibody produced in mouse
N-(3,4-DICHLOROPHENYL)-2-(2-(1H-INDOL-3-YLMETHYLENE)HYDRAZINO)-2-OXOACETAMIDE765275-50-1C17H12Cl2N4O2
N,N′-Methylenebisacrylamide ready-to-use solution "BIS" 2%C7H10N2O2
Allyltriisopropylsilane24400-84-8C12H26Si
TSKgel® CN-80Ts HPLC Column
2-(1-(2-Morpholinoethyl)-1H-benzo[d]imidazol-2-yl)ethanamine
3-Hydroxy-DL-kynurenine-(butyric-1,2-13C2) dihydrobromide1313734-57-4C10H12N2O4
UNG1 (AB1) Blocking Peptide for PRS3863
Boc-Glu-OH2419-94-5C10H17NO6
(5Z)-3-SEC-BUTYL-5-[(1,3-DIPHENYL-1H-PYRAZOL-4-YL)METHYLENE]-2-THIOXO-1,3-THIAZOLIDIN-4-ONE624724-34-1C23H21N3OS2
8-AMINO-1,3-DIMETHYL-7-(1-NAPHTHYLMETHYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE476480-20-3C18H17N5O2
N-(2,2,2-TRICHLORO-1-(3-(4-NITRO-PHENYL)-THIOUREIDO)-ETHYL)-ACETAMIDE303046-60-8
SeQuant ZIC-HILIC 5μm,200 250 x 4.6 mm
1-HydroxypiperidinePiperidin-1-ol4801-58-5C5H11NO
METHYL (2E)-2-(2-FLUOROBENZYLIDENE)-7-METHYL-3-OXO-5-(2-THIENYL)-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE324071-32-1C20H15FN2O3S2
2-{(3Z)-3-[3-(2-METHOXYETHYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]-2-OXO-2,3-DIHYDRO-1H-INDOL-1-YL}-N-[3-(TRIFLUOROMETHYL)PHENYL]ACETAMIDE378222-09-4C23H18F3N3O4S2
Anti-N-cadherin Antibody, clone 6A9.2
4-Nitrocinnamaldehyde, predominantly trans49678-08-2C9H7NO3
17:0-22:4 PI-d52342575-39-5C48H88NO13P
({5-[3-(3-{[(CARBOXYMETHYL)AMINO]METHYL}-4-HYDROXY-5-ISOPROPYL-2-METHYLPHENYL)-1,1-DIOXIDO-3H-2,1-BENZOXATHIOL-3-YL]-2-HYDROXY-3-ISOPROPYLBENZYL}AMINO)ACETIC ACID883845-96-3
(5E)-3-HEPTYL-5-{[3-(4-METHOXY-3-METHYLPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE}-2-THIOXO-1,3-THIAZOLIDIN-4-ONE1018005-92-9C28H31N3O2S2
5-METHYL-1-(METHYLAMINO)-5H-DIBENZ(B,E)AZEPINE-6,11-DIONE200128-49-0C16H14N2O2
APO-DIRECT-50T(2-8C)
2-[5-(4-FLUOROPHENYL)-3-(2-THIENYL)-4,5-DIHYDRO-1H-PYRAZOL-1-YL]-4-PHENYL-1,3-THIAZOLE296773-31-4C22H16FN3S2
N'(1),N'(10)-BIS(2-(BENZYLOXY)BENZYLIDENE)DECANEDIHYDRAZIDE374692-50-9C38H42N4O4
3-(3,4-DIMETHOXYPHENYL)-N-(2-METHOXY-4-NITROPHENYL)ACRYLAMIDE302549-42-4C18H18N2O6
MOBIUS® FlexReady Solution for XMO2 - XMO3 - Essential Service Plan execution including protocol
VEGF Inhibitor, V1C40H61N11O9
TRIPHENYLBISMUTH BIS(2-CHLOROACETATE)61217-41-2C22H19BiCl2O4
MAP Kinase 2/Erk2 Protein, active, mouse, 10 μg
(16alpha)-3-methoxyestra-1(10),2,4-trien-16-ol
3-PHENYL-4,5,6-TRICHLORO-2-INDOLINONE201216-23-1
(5E)-5-(4-ETHYLBENZYLIDENE)-2-(4-METHYLPHENYL)[1,3]THIAZOLO[3,2-B][1,2,4]TRIAZOL-6(5H)-ONE606954-54-5C20H17N3OS
O-(3-Carboxypropyl)-O′-[2-(3-mercaptopropionylamino)ethyl]-polyethylene glycol1220112-75-3(C2H4O)nC9H17NO4S
Anti-PPHLN1 antibody produced in rabbit
Monoclonal Anti-PMFBP1 antibody produced in mouse
2-CHLORO-3-(3-NITROANILINO)-1,4-NAPHTHOQUINONE84348-88-9C16H9ClN2O4
Ethyl (2-methylbenzoyl)acetate51725-82-7C12H14O3
Anti-Cytokeratin, pan antibody, Mouse monoclonal
Lawesson reagent2,4-Bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetan-2,4-disulfid19172-47-5C14H14O2P2S4
(1R,2S)-2-(2-HYDROXY-3-PENTYNYL)-3-CYCLOPENTEN-1-OL1217494-90-0C10H14O2
2-(allylamino)-2-(2-chlorophenyl)cyclohexanone hydrochloride
N-(4-((2,4-DIMETHOXY-BENZYLIDENE)-AMINO)-PHENYL)-ACETAMIDE329934-20-5C17H18N2O3
RCL T18890553945-68-9C17H15N3O2
Nunc® Low Profile Universal Tubes in 2D bar coded latch rack
Anti-CLEC11A antibody produced in rabbit
183 BLCL human cell line
2-{[4,5-BIS(4-CHLOROPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}-N'-{(E)-[4-(METHYLSULFANYL)PHENYL]METHYLIDENE}ACETOHYDRAZIDE497248-18-7C24H19Cl2N5OS2
1,3-BIS(TRIMETHYLSILYLOXY)PROPANE17887-80-8C9H24O2Si2
ETHYL 2-[(OXO{(2E)-2-[2-(TRIFLUOROMETHYL)BENZYLIDENE]HYDRAZINO}ACETYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXYLATE883819-69-0C21H20F3N3O4S
7-(4-CL-PH)-N-(3,4-DIMETHYL-PH)-5-((HYDRAZINO(OXO)AC)HYDRAZONO)-7-OXOHEPTANAMIDE883801-63-6C23H26ClN5O4
Anti-MAP1b antibody, Mouse monoclonal
ISOPROPYL (2E)-2-[4-(BENZYLOXY)BENZYLIDENE]-5-(4-METHOXYPHENYL)-7-METHYL-3-OXO-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE306982-43-4C32H30N2O5S
Transforming Growth Factor-β3 human
1-(2-Chloroethyl)-5-methyl-1H-pyrazole96450-54-3C6H9ClN2
METHYL 2-(3,4-DIHYDRO-3-OXO-2H-1,4-BENZOTHIAZIN-2-YL)ACRYLATE200636-18-6C12H11NO3S
1-Fmoc-4-piperidineacetic acid180181-05-9C22H23NO4
1-(10-{3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl}-10H-phenothiazin-2-yl)ethanone1-(10-(3-(4-(2-Hydroxyethyl)-1-piperidinyl)propyl)-10H-phenothiazin-2-yl)ethanon3819-00-9C24H30N2O2S
2-(dimethylamino)-2-methyl-1-(3-methylphenyl)-1-propanone hydrochlorideC13H20ClNO
Anti-Neuroligin-4
Ro106-992062645-28-7C10H7N5OS
2',6'-DIETHYL-4-METHYLBENZANILIDE200116-58-1C18H21NO
756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860
Copyright 2019 © ChemicalBook. All rights reserved